课题基金 / 基金详情

Gene Therapy against the Progressive Joint Destruction of Rheumatoid Arthritis and Osteoarthritis

Gene Therapy against the Progressive Joint Destruction of Rheumatoid Arthritis and Osteoarthritis
针对类风湿性关节炎和骨关节炎进行性关节破坏的基因疗法
批准号:
13470310
负责人:
SUGAMOTO Kazuomi
金额:
$8.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

SUGAMOTO Kazuomi的其他基金

相似基金

相关文献

中文摘要
翻译
类风湿关节炎(RA)是一种慢性炎症性疾病,伴进行性关节牵伸,在我国有80多万人患有此病。骨关节炎(OA)也是最常见的全身性疾病之一,在不久的将来,随着老年人数量的增加,需要更有效的治疗方法。因此,我们关注NFκB对RA和OA发病过程中炎症因子或蛋白酶的调节作用。我们已经报道了NFκB在关节炎的调节中发挥重要作用,诱饵脱氧核苷酸(ODN)可以通过我们的原始hvj脂质体基因传递系统抑制NFκB的激活。在本研究中,我们制备了RA和OA的实验动物模型,以评估NFκB诱骗ODN对这两种关节炎的关节破坏的作用。我们发现NFκB诱饵ODN通过下调IL-Iβ和TNFα抑制大鼠胶原诱导关节炎(CIA)的恶化,并在猴子中证实了同样的结果。我们建立前交叉韧带横断(ACLT)大鼠作为OA模型。NFκB诱饵ODN对实验性关节炎也有一定的治疗作用。我们得出结论,针对NFκB的诱饵策略是治疗RA和OA的有效候选策略。NFκB诱骗ODN在RA患者关节中的临床应用将随本研究结果而定。
英文摘要
Rheumatoid Arthritis(RA) is a chronic inflammatory disease with the progressive joint distraction, from which more than eight hundred thousands people are suffered in our country. Osteoarthritis(OA) is also one of the most common general disease, and the more effective therapy should be needed when the number of the elderly people will increase in the near future. So we focused on NFκB to modulate the inflammatory cytokines or proteinase which are involved in the pathogenesis of RA and OA. We have already reported that NFκB plays an important role in a regulation of arthritis and decoy deoxynucleotide(ODN) can suppress the activation of NFκB by our original gene delivery system with HVJ-lipoisome. In This investigation, we prepared the experimental animal model of RA and OA to evaluate the efficacy of NFκB decoy ODN against the joint destruction of these arthritis. We showed NFκB decoy ODN suppressed the deterioration of collagen-induced arthritis(CIA) in rats via down-regulation of IL-Iβ and TNFα, and also confirmed the same results with CIA in monkeys. As the OA model, we established the rats with anterior cruciate ligament transection(ACLT). NFκB decoy ODN was also effective to the experimental arthritis. We concluded That the decoy strategy against NFκB is an effective therapeutic candidate for RA and OA. The clinical application of NFκB decoy ODN to the joints of RA patients will be following after these our results.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
Nakase T, Tomita T, et al.: "Involvement of BMP-2 signaling in a cartilage cap in osteochondroma"J Orthop Res. 19. 1085-1088 (2001)
Nakase T、Tomita T 等人:“骨软骨瘤软骨帽中 BMP-2 信号传导的参与”J Orthop Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomita T, et al.: "Differentiation of monocytes into multinucleated giant bone-resorbing cells : two-step differentiation induced by nurse-like"Arthritis Res.. 3. 306-310 (2001)
Tomita T等人:“单核细胞分化为多核巨型骨吸收细胞:护士样诱导的两步分化”Arthritis Res.. 3. 306-310 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakase T, Miyaji T, Kuriyama K, Tamai N, Horiki M, Tomita T, Myoui A, Shimada K, Yoshikawa H.: "Immunohistochemical detection of parathyroid hormone-related peptide. Indian hedgehog, and patched in the process of endochondral ossification in the human."Hi
Nakase T、Miyaji T、Kuriyama K、Tamai N、Horiki M、Tomita T、Myoui A、Shimada K、Yoshikawa H.:“甲状旁腺激素相关肽的免疫组织化学检测。印度刺猬,以及软骨内骨化过程中的补丁”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka S, Tomita T, Yoshikawa H. et al.: "Novel autoantibodies to pituitary gland specific factor 1a in patients with rheumatoid arthritis"Rheumatology. 42(2). 353-356 (2003)
Tanaka S、Tomita T、Yoshikawa H. 等人:“类风湿性关节炎患者垂体特异性因子 1a 的新型自身抗体”风湿病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    Construction of a data base for 3D kinematics of all motion of all human joints.
    • 批准号:
      22300204
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2010
    • 负责人:
      SUGAMOTO Kazuomi
    • 依托单位:
    海外基金